Oxygen carriers as blood substitutes: Past, present, and future

Lawrence T. Goodnough, Mitchell G. Scott, Terri G. Monk

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Prospects for safe and effective blood substitutes are promising, based on clinical trial results of soluble hemoglobin solutions and emulsion of perfluorocarbins. Advantages of blood substitutes include sterilization of viral and bacterial contaminants, room temperature storage, a long shelf life, and absence of ABO and other red cell antigens. Projected arenas for their use include not only military applications but also trauma medicine and elective surgical settings, coupled with acute normovolemic hemodilution. Applications of perfluorocarbons are limited by the need for 100% FIO2. A significant challenge facing development of hemoglobin solutions is their effect on vascular tone through smooth muscle constriction. Development of second or third generation hemoglobin solutions may be necessary so that hemoglobin solutions more closely mimic cellular hemoglobin's nitric oxide binding properties. Optimizing O2 delivery to ischemic tissues and organs may lead to regulatory approval of these agents in this setting before their approval as blood substitutes.

Original languageEnglish
Pages (from-to)89-100
Number of pages12
JournalClinical orthopaedics and related research
Issue number357
DOIs
StatePublished - Jan 1 1998

Fingerprint Dive into the research topics of 'Oxygen carriers as blood substitutes: Past, present, and future'. Together they form a unique fingerprint.

  • Cite this